BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Science in Seattle - ECPv6.18.3//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Science in Seattle
X-ORIGINAL-URL:https://scienceinseattle.com
X-WR-CALDESC:Events for Science in Seattle
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Vancouver
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20170312T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20171105T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20180311T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20181104T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20190310T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20191103T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20181108T180000
DTEND;TZID=America/Vancouver:20181108T203000
DTSTAMP:20181029T200532Z
CREATED:20181029T200532Z
LAST-MODIFIED:20181029T200532Z
UID:4769-1541700000-1541709000@scienceinseattle.com
SUMMARY:Parenteral Drug Association Pacific Northwest Chapter Kickoff and Welcome Reception
DESCRIPTION:Join us at the Parenteral Drug Association Pacific Northwest Chapter kickoff and welcome reception on November 8\, 2018 from 6:00 – 8:30 pm at Aptevo Therapeutics in Seattle. The PDA PNW chapter was chartered in 2018 to provide a local forum through which technical professionals in Washington\, Oregon\, Idaho\, Alaska\, and British Columbia could support the advancement of pharmaceutical and biopharmaceutical science and technology. \nThis inaugural event will be attended by Richard Johnson\, President and CEO of the PDA\, who will discuss the PDA’s organizational structure\, mission\, and role in guiding parenteral drug development. The event will also feature a keynote presentation by your local FDA compliance officers\, Maria Kelly-Doggett and William Millar\, who will be discussing lifecycle management of parenteral drugs. Officers Kelly-Doggett and Millar will also be fielding questions and providing information on local FDA resources. \nThere will be ample opportunities to network and connect with local experts and peers in the field. Help us celebrate the formation of our new local PDA chapter\, and become a part of the rapidly growing PNW-based pharmaceutical and biopharmaceutical community to ensure our voices are heard at the national level. \nDinner and drinks will be provided. Hope to see you there! \nPresenters\nRichard M. Johnson was named President and CEO of the Parenteral Drug Association in September 2009. In his more than 30-year career in the pharmaceutical and medical devices industry\, Richard has been a recognized leader with excellent knowledge of US and international regulatory requirements\, quality practices\, and technical operations\, especially in validation\, sterilization\, aseptic and sterile processing. Richard has M.Sc. and B.Sc. degrees in Biological Sciences from Marshall University. \nMaria Kelly-Doggett is a Bothell\, Washington-based FDA compliance officer within the Office of Regulatory Affairs\, Office of Pharmaceutical Quality Operations\, Division IV.  She joined FDA in 2008 as an investigator and conducted domestic and foreign drug and BIMO inspections until she became a compliance officer in 2014.  Prior to joining the agency\, Ms. Kelly-Doggett worked for twelve years in the pharmaceutical industry. Ms. Kelly-Doggett holds a B.S. in Chemical Engineering from North Carolina State University\, and a M.B.A. from Meredith College\, located in Raleigh\, North Carolina. \nWilliam Millar is a Portland\, Oregon-based FDA compliance officer within the Office of Regulatory Affairs\, Office of Pharmaceutical Quality Operations\, Division IV.  He joined FDA in 2008 as an investigator and conducted domestic and foreign drug inspections until he became a compliance officer in 2012.  Prior to joining the agency\, Mr. Millar worked in the San Francisco Bay Area pharmaceutical industry for twelve years.  Mr. Millar holds a B.S. in Biochemistry from the University of Nevada-Reno\, and a M.B.A. from Holy Names College\, located in Oakland\, California.
URL:https://scienceinseattle.com/event/parenteral-drug-association-pacific-northwest-chapter-kickoff-welcome-reception/
LOCATION:Aptevo Therapeutics\,  2401 4th Ave\, Seattle\, WA\, 98121\, United States
ATTACH;FMTTYPE=image/jpeg:https://scienceinseattle.com/wp-content/uploads/sites/4/2018/10/PDA-e1540843496523.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20181108T180000
DTEND;TZID=America/Vancouver:20181108T203000
DTSTAMP:20181029T200532Z
CREATED:20181029T200532Z
LAST-MODIFIED:20181029T200532Z
UID:25347-1541700000-1541709000@scienceinseattle.com
SUMMARY:Parenteral Drug Association Pacific Northwest Chapter Kickoff and Welcome Reception
DESCRIPTION:Join us at the Parenteral Drug Association Pacific Northwest Chapter kickoff and welcome reception on November 8\, 2018 from 6:00 – 8:30 pm at Aptevo Therapeutics in Seattle. The PDA PNW chapter was chartered in 2018 to provide a local forum through which technical professionals in Washington\, Oregon\, Idaho\, Alaska\, and British Columbia could support the advancement of pharmaceutical and biopharmaceutical science and technology. \nThis inaugural event will be attended by Richard Johnson\, President and CEO of the PDA\, who will discuss the PDA’s organizational structure\, mission\, and role in guiding parenteral drug development. The event will also feature a keynote presentation by your local FDA compliance officers\, Maria Kelly-Doggett and William Millar\, who will be discussing lifecycle management of parenteral drugs. Officers Kelly-Doggett and Millar will also be fielding questions and providing information on local FDA resources. \nThere will be ample opportunities to network and connect with local experts and peers in the field. Help us celebrate the formation of our new local PDA chapter\, and become a part of the rapidly growing PNW-based pharmaceutical and biopharmaceutical community to ensure our voices are heard at the national level. \nDinner and drinks will be provided. Hope to see you there! \nPresenters\nRichard M. Johnson was named President and CEO of the Parenteral Drug Association in September 2009. In his more than 30-year career in the pharmaceutical and medical devices industry\, Richard has been a recognized leader with excellent knowledge of US and international regulatory requirements\, quality practices\, and technical operations\, especially in validation\, sterilization\, aseptic and sterile processing. Richard has M.Sc. and B.Sc. degrees in Biological Sciences from Marshall University. \nMaria Kelly-Doggett is a Bothell\, Washington-based FDA compliance officer within the Office of Regulatory Affairs\, Office of Pharmaceutical Quality Operations\, Division IV.  She joined FDA in 2008 as an investigator and conducted domestic and foreign drug and BIMO inspections until she became a compliance officer in 2014.  Prior to joining the agency\, Ms. Kelly-Doggett worked for twelve years in the pharmaceutical industry. Ms. Kelly-Doggett holds a B.S. in Chemical Engineering from North Carolina State University\, and a M.B.A. from Meredith College\, located in Raleigh\, North Carolina. \nWilliam Millar is a Portland\, Oregon-based FDA compliance officer within the Office of Regulatory Affairs\, Office of Pharmaceutical Quality Operations\, Division IV.  He joined FDA in 2008 as an investigator and conducted domestic and foreign drug inspections until he became a compliance officer in 2012.  Prior to joining the agency\, Mr. Millar worked in the San Francisco Bay Area pharmaceutical industry for twelve years.  Mr. Millar holds a B.S. in Biochemistry from the University of Nevada-Reno\, and a M.B.A. from Holy Names College\, located in Oakland\, California.
URL:https://scienceinseattle.com/event/parenteral-drug-association-pacific-northwest-chapter-kickoff-welcome-reception-2/
LOCATION:Aptevo Therapeutics\,  2401 4th Ave\, Seattle\, WA\, 98121\, United States
ATTACH;FMTTYPE=image/jpeg:https://scienceinseattle.com/wp-content/uploads/sites/4/2018/10/PDA-e1540843496523.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20181108T180000
DTEND;TZID=America/Vancouver:20181108T203000
DTSTAMP:20181029T200532Z
CREATED:20181029T200532Z
LAST-MODIFIED:20181029T200532Z
UID:26312-1541700000-1541709000@scienceinseattle.com
SUMMARY:Parenteral Drug Association Pacific Northwest Chapter Kickoff and Welcome Reception
DESCRIPTION:Join us at the Parenteral Drug Association Pacific Northwest Chapter kickoff and welcome reception on November 8\, 2018 from 6:00 – 8:30 pm at Aptevo Therapeutics in Seattle. The PDA PNW chapter was chartered in 2018 to provide a local forum through which technical professionals in Washington\, Oregon\, Idaho\, Alaska\, and British Columbia could support the advancement of pharmaceutical and biopharmaceutical science and technology. \nThis inaugural event will be attended by Richard Johnson\, President and CEO of the PDA\, who will discuss the PDA’s organizational structure\, mission\, and role in guiding parenteral drug development. The event will also feature a keynote presentation by your local FDA compliance officers\, Maria Kelly-Doggett and William Millar\, who will be discussing lifecycle management of parenteral drugs. Officers Kelly-Doggett and Millar will also be fielding questions and providing information on local FDA resources. \nThere will be ample opportunities to network and connect with local experts and peers in the field. Help us celebrate the formation of our new local PDA chapter\, and become a part of the rapidly growing PNW-based pharmaceutical and biopharmaceutical community to ensure our voices are heard at the national level. \nDinner and drinks will be provided. Hope to see you there! \nPresenters\nRichard M. Johnson was named President and CEO of the Parenteral Drug Association in September 2009. In his more than 30-year career in the pharmaceutical and medical devices industry\, Richard has been a recognized leader with excellent knowledge of US and international regulatory requirements\, quality practices\, and technical operations\, especially in validation\, sterilization\, aseptic and sterile processing. Richard has M.Sc. and B.Sc. degrees in Biological Sciences from Marshall University. \nMaria Kelly-Doggett is a Bothell\, Washington-based FDA compliance officer within the Office of Regulatory Affairs\, Office of Pharmaceutical Quality Operations\, Division IV.  She joined FDA in 2008 as an investigator and conducted domestic and foreign drug and BIMO inspections until she became a compliance officer in 2014.  Prior to joining the agency\, Ms. Kelly-Doggett worked for twelve years in the pharmaceutical industry. Ms. Kelly-Doggett holds a B.S. in Chemical Engineering from North Carolina State University\, and a M.B.A. from Meredith College\, located in Raleigh\, North Carolina. \nWilliam Millar is a Portland\, Oregon-based FDA compliance officer within the Office of Regulatory Affairs\, Office of Pharmaceutical Quality Operations\, Division IV.  He joined FDA in 2008 as an investigator and conducted domestic and foreign drug inspections until he became a compliance officer in 2012.  Prior to joining the agency\, Mr. Millar worked in the San Francisco Bay Area pharmaceutical industry for twelve years.  Mr. Millar holds a B.S. in Biochemistry from the University of Nevada-Reno\, and a M.B.A. from Holy Names College\, located in Oakland\, California.
URL:https://scienceinseattle.com/event/parenteral-drug-association-pacific-northwest-chapter-kickoff-welcome-reception-3/
LOCATION:Aptevo Therapeutics\,  2401 4th Ave\, Seattle\, WA\, 98121\, United States
ATTACH;FMTTYPE=image/jpeg:https://scienceinseattle.com/wp-content/uploads/sites/4/2018/10/PDA-e1540843496523.jpg
END:VEVENT
END:VCALENDAR